Effect of growth hormone-release inhibiting hormone on hormones stimulating exocrine pancreatic secretion.
The nature and extent of growth hormone-release inhibiting hormone (GH-RIH, somatostatin)-induced inhibition of pancreatic secretion of bicarbonate and protein, an index of enzyme secretion, were studied by administration of exogenous secretin or cholecystokinin (CCK) and of a number of stimulants for endogenous release of these hormones in fasted pancreatic fistula dogs with and without an infusion of GH-RIH. The results of this study show that GH-RIH inhibits the pancreatic fluid and bicarbonate secretion induced by duodenal acidification and exogenous secretion. The kinetic analysis shows that the interaction between GH-RIH and secretin affecting pancreatic bicarbonate secretion possesses the characteristics of competitive inhibition. GH-RIH does not change the pancreatic protein response to exogenous CCK, but profoundly inhibits pancreatic response to a variety of the endogenous stimulants of CCK release, including duodenal perfusion of sodium oleate, amino acid mixture, or feeding of a peptone meal. We conclude that GH-RIH is a very potent inhibitor of the endogenous release of CCK from the intestinal mucosa and inhibits competitively the action of secretin but not CCK on the exocrine pancreatic secretion.
D000818:Animals; D001639:Bicarbonates / Q000378:metabolism; D002766:Cholecystokinin; D003864:Depression, Chemical; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005747:Gastric Fistula; D005750:Gastric Juice / Q000378:metabolism; D009829:Oleic Acids / Q000494:pharmacology; D010179:Pancreas / Q000378:metabolism*; D010185:Pancreatic Fistula; D010455:Peptides; D011506:Proteins / Q000378:metabolism; D012633:Secretin; D013004:Somatostatin / Q000494:pharmacology*
D001639:Bicarbonates; D009829:Oleic Acids; D010455:Peptides; D011506:Proteins; D012633:Secretin; D013004:Somatostatin; D002766:Cholecystokinin